Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-613

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 51655-613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (51655 613 52)

Label (51655 613 52)
This is a bottle of 30 film-coated tablets of Atorvastatin Calcium, USP, 10mg strength. It's labeled with NDC code 51655-613-52 and has a prescription-only status. The suggested storage temperature ranges between 20°C-25°C (68°F-77°F), with excursions up to 15°C (59°F) to 30°C (86°F) allowed. The tablets should be kept away from children and stored in their original container. The GTIN is 0035655613528, and the serial number is 000000000000000. The package insert provides dosage information. This bottle has been repackaged by Northwind Pharmaceuticals from Apotex Corp. Lot number and expiration dates are all zeros.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
This is a graph that shows the Cumulative Hazard percentages of Atorvastatin over a period of four years. The medication Atorvastatin is shown to have a Hazard Ratio (HR) of 05.3 with a 95% confidence interval ranging from 0.45 to 0.83. However, there is not enough information to interpret the units on the x-axis.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
The given text seems to be a snippet of a statistical or medical report in which an experiment was conducted, and the subjects were given Horvastatin and Sorvastatin, both of different quantities. The table shows the percentage of subjects that experienced "E vert" which might be a medical condition. The experiment also resulted in a given HR and P-value. Furthermore, the chart shows the time in years taken to reach the first Major Cardiovascular End Point.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.